Oncology Times

@oncologytimes.bsky.social

By detecting free-floating microscopic bits of DNA shed by tumors into the bloodstream, a team led by researchers at the Dana-Farber Cancer Institute was able to isolate a subset of patients with Stage III colon cancer who might significantly benefit from celecoxib. ow.ly/OVWp50Varf8

Bild